As I was considering topics for the April issue of MedMarkets, I came across a story in Reuters that aspirin was associated with reduced incidence and mortality from cancer. That aspirin should have such a therapeutic benefit was not surprising, especially considering the data that has been appearing from different sources that inflammation (aspirin is [...]
bookmark to
